Global Pharmaceutical Drug Delivery Market Size study & Forecast, by Route Of Administration (Oral drug delivery system, Nasal drug delivery system, Ocular drug delivery systems, Topical drug delivery system, Other drug delivery system) by Application (Ca

Global Pharmaceutical Drug Delivery Market Size study & Forecast, by Route Of Administration (Oral drug delivery system, Nasal drug delivery system, Ocular drug delivery systems, Topical drug delivery system, Other drug delivery system) by Application (Cancer, Diabetes, Cardiovascular Diseases, Others) and Regional Analysis, 2022-2029

Global Pharmaceutical Drug Delivery Market is valued at approximately USD 1377.28 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.7% over the forecast period 2022-2029. Pharmaceutical drug delivery is a formulation or device used to administer a medicinal material into the body. This technique works by delivering pharmaceuticals to the body's targeted areas with the use of a medium that can control the administration of the therapy using either a chemical or a physiological trigger. The different routes by which pharmaceutical medications are administered are oral, intravenous injection, cutaneous absorption, and inhalation. The global market growth is being driven by the factors such as high incidences of chronic diseases among the population, surging demand for biosimilars and biologics, increasing government support for research in the field of drug delivery, and rising concerns & awareness about health care. The World Health Organization stated that cardiovascular diseases account for the leading cause of death with around 17.9 million cases worldwide. Similarly, according to the International Diabetes Federation, the diabetic population is likely to reach 783 million by the year 2045.

In addition, the growing investments in pharmaceutical R&D are acting as a catalyzing factor for the growth of the market across the globe. The globalization of healthcare has expanded the scope of pharmaceuticals, which represents significant growth opportunities. Pharmaceutical companies are investing in R&D to develop drugs that are tailored to the specific needs of the customers. As per Statista, in 2020, the total overall R&D spending in the pharmaceutical sector accounted for USD 207 billion and it is projected to reach around USD 265 billion by the year 2025. Thereby, the increasing investments in pharmaceutical R&D are attributed to market development. Moreover, the growing trend of self-administration and home care, as well as increasing technological advancements and new product launches are presenting various lucrative opportunities over the forecasting years. However, the increasing number of drug recalls and drug failures is challenging the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Pharmaceutical Drug Delivery Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the easy availability of pharmaceutical drug delivery systems, rising government support, rising government initiatives, along with modernize healthcare infrastructure. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the increasing incidences of chronic diseases including cancer, respiratory allergies, and diabetes, rising awareness regarding the use of pharmaceutical drug delivery products as well as the growth of the life science industry across the APAC region.

Major market players included in this report are:
Bayer AG
Becton, Dickinson and Company
F. Hoffmann-La Roche AG
GlaxoSmithKline Plc
Johnson & Johnson Private Limited
Merck & Co., Inc.
Novartis AG
3M Company
Pfizer Inc.
Sanofi S.A.

Recent Developments in the Market:
 In June 2020, GlaxoSmithKline plc partnered with IDEAYA to enter the field of synthetic lethality, which continues to advance in oncology. The clinical trials for its programs MAT2A, Pol Theta, and Werner Helicase are anticipated to begin within the next three years.
 In July 2021, Johnson & Johnson received FDA approval for DARZALEX (daratumumab), a subcutaneous formulation that shortens the duration of treatment for multiple myeloma patients.

Global Pharmaceutical Drug Delivery Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Route Of Administration, Application, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Route Of Administration:
Oral drug delivery system
Nasal drug delivery system
Ocular drug delivery systems
Topical drug delivery system
Other drug delivery system
By Application:
Cancer
Diabetes
Cardiovascular Diseases
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned
Bayer AG
Becton, Dickinson and Company
F. Hoffmann-La Roche AG
GlaxoSmithKline Plc
Johnson & Johnson Private Limited
Merck & Co., Inc.
Novartis AG
3M Company
Pfizer Inc.
Sanofi S.A.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.